BLOG / 🇺🇸 United States / broad market · · daily

US SEC Filings Daily Market Digest — November 05, 2026

Daily USA Market Intelligence

By Gunpowder Editorial ·

18 high priority 32 medium priority 50 total filings analysed

Executive Summary

The November 5, 2026 filing slate is dominated by a stark divergence between top-line growth and bottom-line quality: of the ~20 operating companies reporting, 14 posted revenue growth (median ~+10% YoY) yet 11 showed GAAP earnings declines or margin compression, driven by derivative losses (Chord -$246M), one-time tax/legal items (Priority, Aemetis 45Z true-up), and rising interest expense (Ormat +24%, Oncor +30%, Dyne +105%).

M&A is the single biggest theme: Lantheus-Curium ($8.0B, guidance suspended), Priority-WD Capital ($8.05/share take-private), NorthWestern-Black Hills (Montana PSC decision due before Nov 12), National Fuel's Seneca spin (H2 2027), and the completed EQR/AVB merger forming Vivmark (Core FFO +5.1%). Capital allocation is bifurcated: Ralph Lauren deployed $626.6M on buybacks exceeding FCF while cash fell 28.3%, Watts cut long-term debt 51%, Holley prepaid $25M, and CION cut debt from $1.17B to $897M. Credit and liquidity stress is visible at the small-cap tail: Perma-Fix going-concern doubt, Aemetis $377M current debt vs $3.4M cash, Baird Medical Nasdaq bid deficiency, and First Bancorp NPLs up to 0.58% from 0.40%. The 13F cohort (17 filers) confirms institutional positioning remains overwhelmingly passive/mega-cap tech, with only Belvedere showing meaningful options/derivatives and crypto-ETF exposure.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 10-Q · 13F

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from November 04, 2026.

Investment Signals (12)

  • ▲

    Revenue +36.6% YoY to $367.7M with shipments +30.6%, non-GAAP operating income nearly doubled to $66.2M from $36.5M, and FY2026 guidance raised to $1.24-$1.28B from $1.125-$1.175B; GAAP net income of just $1.5M was purely a $39.1M mark-to-market investment loss, not operating weakness

  • Net income +76.9% YoY to $145.4M (EPS $4.34 vs $2.45), nine-month net income +41.3%, and long-term debt cut ~51% ($197.7M to $98.2M) — the strongest quality-of-earnings profile in the slate

  • ▲

    Q2 FY27 revenue +9.1% to $2,193.3M, gross margin expanded 620 bps to 74.2%, EPS +46.7% to $4.87, and six-month operating cash flow nearly tripled to $618.2M from $229.3M

  • Q3 net income +50.5% to $572M and nine-month +47.8% to $1,212M on new base rates effective June 1, 2026, customer growth, and warmer weather; nine-month operating cash flow +58.7%

  • FY2026 adjusted EPS $7.55 (+9% YoY) and GAAP EPS $7.02 vs $5.68; announced Seneca Resources upstream spin-off for H2 2027 plus closed Ohio gas utility acquisition — a sum-of-the-parts catalyst

  • Vivmark Residential (EQR/AVB) (BULLISH)
    ▲

    Core FFO/share +5.1% to $1.03, blended lease rate improved to +3.1% from -3.4% new-lease trough in Q1 2026, and S&P upgraded both legacy issuers to 'A' from 'A-' on Aug 18

  • Agenus ↓ (BULLISH)
    ▲

    Third consecutive positive operating income quarter ($11.4M), net income $2.8M vs prior losses, and cash jumped to $86.9M from $18.7M after an ~$85M private placement with up to ~$255M more via milestone warrants

  • Nine-month operating cash flow +47.0% to $2,405.0M and nine-month net income $815.4M vs a $(40.0)M loss; Q3 GAAP hit was a non-cash $(246.0)M derivative loss, not operational [BULLISH — operational, BEARISH — reported EPS]

  • ▲

    Q3 net income swung to $7.8M from a $(0.8)M loss, adjusted EBITDA +8.6% to $29.4M with margin at 20.8%, core business +6.7% ex-divestitures, and $25M debt prepaid bringing leverage to 3.50x

  • ▲

    Revenue +30.1% YoY to $962.3M but operating income -52.2%, EPS $0.42 vs $0.89, gross margin compressed to ~12.2% from 14.5%, and operating cash flow swung to -$42.3M — growth is being bought with margin and working capital

  • ▲

    Q3 revenue -11.5% to $426.8M, net income -64.3% to $32.5M, operating income nearly halved to $52.4M from $127.7M, and license revenue -17.0% — a sharp billings/backlog deterioration masked by flat nine-month revenue

  • ▲

    Nine-month operating income collapsed 78.7% to $10.5M as sales & marketing surged to $115.4M from $96.9M, stockholders' deficit widened to $(263.7)M, and cash fell to $27.4M from $70.1M

Risk Flags (10)

  • ▼

    Management continues to disclose substantial doubt about going-concern status; Treatment Segment gross margin collapsed to (1.9%) from 17.3%, consolidated gross profit fell to $552K from $2.6M, nine-month loss from continuing ops widened to $17.0M from $7.8M, and nine-month EBITDA was $(15.9)M

  • Aemetis↓ [HIGH RISK]
    ▼

    Current portion of long-term debt ($316.4M) plus short-term borrowings ($60.5M) total $376.9M against $3.4M cash and $29.1M current assets; stockholders' deficit widened to $(314.2)M; Q3 profit relied on a ~$11.0M one-time 45Z true-up and diluted EPS was $(0.02) vs basic $0.07

  • Dyne Therapeutics↓ [HIGH RISK]
    ▼

    Q3 net loss widened 79% to $193.6M, R&D +66% and G&A +112%, interest expense +105% to $5.9M, and nine-month operating cash burn of $452.7M against $1.13B cash — runway depends on continued equity access

  • Novavax↓ [HIGH RISK]
    ▼

    Nine-month revenue fell 72.9% to $264.5M from $976.3M, nine-month net loss $94.3M vs $422.8M income a year ago, stockholders' deficit widened to $216.9M, and deferred revenue declined on both current and non-current lines

  • Baird Medical↓ [HIGH RISK]
    ▼

    Nasdaq notice dated Nov 2, 2026 for 30 consecutive days below $1.00; 180-day cure period to May 3, 2027 with a possible second 180-day period requiring a written cure plan — delisting overhang

  • Priority Technology↓ [MEDIUM-HIGH RISK]
    ▼

    GAAP net income -55.7% to $12.2M and diluted EPS -58.8% to $0.14, gross margin -110 bps to 36.1%, guidance and earnings call suspended pending the $8.05/share take-private — deal-spread risk if H1 2027 close slips

  • CION Investment Corp↓ [MEDIUM-HIGH RISK]
    ▼

    NAV/share fell 2.7% to $13.20, net loss of $(0.07)/share vs $0.62 NII in Q2, non-accruals rose to 1.63% of fair value from 1.44%, and net realized losses of $9.2M — BDC asset quality deteriorating even as leverage falls to 1.30x

  • First Bancorp (ME) [MEDIUM RISK]
    ▼

    Non-performing loans rose to 0.58% of total loans from 0.40%, and a $11.7M quarterly OCI loss on AFS securities pushed comprehensive income to a $(1.0)M loss despite +17.5% net income

  • Playtika↓ [MEDIUM RISK]
    ▼

    Nine-month net income fell 70.0% to $30.9M on a $177.0M contingent consideration swing and $132.0M higher G&A; operating cash flow -20.4% to $224.4M and cash/short-term investments down to $594.6M from $820.2M

  • Macerich↓ [MEDIUM RISK]
    ▼

    Nine-month operating cash flow -6.5% to $253.7M, leasing expenses +46.6% in Q3, JV equity income swung to an $8.1M nine-month loss from +$8.5M, and interest costs remain elevated despite the equity raise

Opportunities (10)

  • ◆

    All-cash deal at up to $114.50/share (~$8.0B) with guidance suspended and no Q3 call; Neuraceq revenue +123.0% to $45.6M and PYLARIFY TruVu pass-through effective Oct 1, 2026 support the strategic rationale — spread opportunity if regulatory timeline firms

  • National Fuel Gas Spin-Off (OPPORTUNITY)
    ◆

    Seneca Resources separation in H2 2027 plus FY2027 adjusted EPS guidance of $6.00-$6.40 (vs $7.55 FY2026, reflecting the utility-only mix); sum-of-the-parts re-rating likely as the pure-play utility emerges

  • Vivmark Residential (OPPORTUNITY)
    ◆

    Blended lease rate inflected to +3.1% in Q3 from -3.4% new-lease trough in Q1 2026, Core FFO +5.1%, and an 'A' credit rating — merger synergies and lease momentum are underappreciated versus the GAAP EPS noise from $0.92/share merger costs

  • ACM Research↓ (OPPORTUNITY)
    ◆

    FY2026 guidance raised ~10% at the midpoint ($1.24-$1.28B), Lingang second building online in Q4 doubles manufacturing floor space, and the first 310×310mm panel-level ECP tool shipped to an Asian customer — GAAP/investment-loss distortion creates a valuation gap

  • Agenus↓ (OPPORTUNITY)
    ◆

    First global marketing authorizations (Armenia) for BOT+BAL in MSS mCRC, three consecutive positive operating-income quarters, and warrant milestones (60-patient enrollment Q2 2027; interim pathologic response H2 2027) that could unlock up to ~$255M

  • Holley Inc.↓ (OPPORTUNITY)
    ◆

    Leverage down to 3.50x after $25M prepayment, adjusted EBITDA margin at 20.8%, and a large QSR-adjacent 3,000-store renovation program at LSI plus Holley's own core +6.7% growth — deleveraging story with a narrowed guidance reset already priced

  • Montana PSC decision expected before Nov 12, 2026; 2026 non-GAAP EPS guidance of $3.68-$3.83 affirmed with a 4%-6% long-term growth rate and $0.67 quarterly dividend — binary regulatory catalyst within days

  • Chord Energy↓ (OPPORTUNITY)
    ◆

    Nine-month operating cash flow +47% to $2,405.0M and equity up to $8,266.6M; the $(246.0)M Q3 derivative loss is non-cash and reverses with strip pricing — free-cash-flow yield disconnect

  • Adjusted EBITDA +41% to $22.2M, free cash flow $13.8M, $0.05 dividend, and a 3,000-store QSR interior renovation program starting late fiscal Q3 2027 — Royston integration masks organic lighting softness (-2% ex-acquisition) [OPPORTUNITY — catalyst-dated]

  • Ormat Technologies↓ (OPPORTUNITY)
    ◆

    Energy storage revenue +145.1% to $49.9M, nine-month revenue +31.5% to $937.8M, capex down 10.6%, and 2031 convertibles issued at $1,000.0M with 2027 notes prepaid — storage inflection offsets flat electricity revenue

Sector Themes (6)

  • Growth Without Earnings Quality
    ◆

    Across 14 revenue-growing reporters, GAAP earnings diverged sharply from operating trends — Chord's $(246.0)M derivative loss, ACM's $39.1M investment mark, Aemetis's ~$11.0M 45Z true-up, Priority's $21.2M prior-year tax benefit, and ACI's $25.9M prior-year equity gain all distorted headline EPS; investors should anchor on adjusted EBITDA and cash flow this quarter [IMPLICATION: favor cash-flow-based valuation]

  • M&A Wave Reshaping Mid-Caps
    ◆

    Five separate transactions in one day — Lantheus/Curium ($8.0B), Priority/WD Capital ($8.05/share), NorthWestern/Black Hills (close by YE2026), EQR/AVB completed as Vivmark, and National Fuel's Seneca spin — with three of five suspending guidance or calls, reducing forward disclosure and raising deal-spread trading [IMPLICATION: event-driven strategies favored over fundamental]

  • Interest Expense Outpacing Revenue
    ◆

    Ormat +24.6% nine-month, Oncor +29.9% Q3, Dyne +105%, ScanSource interest expense up 63%, and Macerich leverage costs elevated — even as several companies deleveraged (Watts -51% LTD, CION -$273M debt, Holley -$25M), the cost of carry is compressing margins for the leveraged cohort [IMPLICATION: balance-sheet quality is the differentiator]

  • Small-Cap Liquidity Stress at the Tail
    ◆

    Perma-Fix going-concern doubt, Aemetis $377M current debt vs $3.4M cash, Baird Medical sub-$1 bid, Envoy Medical $14.6M cash after equity raise, and Leapfrog SPAC operating cash -37.1% — the micro-cap cohort is increasingly dependent on capital markets access [IMPLICATION: avoid binary liquidity risk]

  • Passive/Mega-Cap Concentration in Institutional Portfolios
    ◆

    Of 17 13F filers, the overwhelming majority are ETF/index-dominated with Apple, Microsoft, NVIDIA, Alphabet, and Amazon as top single names; only Belvedere shows meaningful options/derivatives and crypto-ETF exposure (Bitwise Bitcoin, Hyperliquid, Solana, XRP) [IMPLICATION: institutional flows remain beta-driven, limiting alpha in large caps]

  • Capital Returns Bifurcation
    ◆

    Ralph Lauren spent $626.6M on buybacks exceeding FCF (cash -28.3%), Watts cut debt 51%, Holley prepaid $25M, CION declared $0.25 Q1 2027 distributions, and LSI/First Bancorp/NorthWestern raised or maintained dividends — mature companies are prioritizing balance sheet and shareholder returns over growth capex [IMPLICATION: dividend-growth and deleveraging screens outperform]

Watch List (8)

  • Montana PSC merger decision with Black Hills expected before November 12, 2026 — binary regulatory catalyst within days; watch for PCCAM waiver approval and Colstrip cost recovery

  • Curium merger at up to $114.50/share (~$8.0B) pending; guidance suspended and no Q3 call — monitor regulatory approvals and any go-shop or financing developments

  • $8.05/share take-private by WD Capital Partners expected to close H1 2027 — watch for proxy filing, financing conditions, and any competing bid

  • Seneca Resources spin-off targeted H2 2027; FY2027 adjusted EPS guidance of $6.00-$6.40 — monitor Form 10 registration and separation tax treatment

  • 180-day Nasdaq compliance window to May 3, 2027; watch for reverse-split announcement or cure plan filing, and the Nov 4 volatility press release follow-through

  • 👁

    $376.9M current debt vs $3.4M cash — watch for refinancing, 45Z credit monetization, and whether Q4 reverses the one-time true-up benefit

  • Going-concern disclosure — monitor Q4 Treatment Segment volumes after September Hanford waste processing restart and thermal system upgrades

  • Lingang second building online in Q4 2026 (doubles floor space) and FY2026 guidance of $1.24-$1.28B — watch Q4 shipments and gross margin recovery toward the 42%-48% target

Filing Analyses (50)
INTERNATIONAL BANCSHARES CORP 8-K mixed materiality 6/10

05-11-2026

International Bancshares Corporation reported Q3 2026 net income of $114.5 million ($1.84 diluted EPS), up 5.6% in net income and 5.7% in diluted EPS from $108.4 million ($1.74) in Q3 2025. Nine-month 2026 net income was $312.5 million ($5.02 diluted EPS), up 2.3% and 2.2% respectively from $305.4 million ($4.91) a year earlier, indicating that growth slowed considerably on a year-to-date basis. Total assets reached approximately $17.3 billion at September 30, 2026, up from $16.6 billion at December 31, 2025.

  • · Year-to-date growth (2.3% net income, 2.2% diluted EPS) lagged the Q3 quarterly growth rate (5.6%, 5.7%), indicating deceleration over the nine-month period
  • · Net interest income benefited from a decrease in interest expense driven by a redistribution in deposit rates, and management says it is closely monitoring deposit rates to stay competitive
  • · Net income was also positively impacted by earnings from other investments
  • · IBC listed on TXSE effective October 19, 2026, as one of the initial corporate listers
Chord Energy Corp 10-Q mixed materiality 8/10

05-11-2026

Chord Energy Corp (CHRD) reported Q3 2026 total revenues of $1,705.9M, up 30.0% YoY from $1,312.1M, and net income of $181.6M versus $130.1M in Q3 2025 (+39.6%). Nine-month net income reached $815.4M versus a net loss of $(40.0)M in the prior-year period, though Q3 results were weighed down by a $(246.0)M derivative loss, and Q3 derivative losses also drove other expense to $(259.4)M from $(0.5)M a year earlier. Net debt-related and operating cost pressures persisted, with production taxes rising 45.7% YoY in Q3 and interest expense up 42.9%.

  • · Q3 2026 operating income rose to $505.0M from $170.8M, but a $(246.0)M derivative loss in Q3 2026 (versus a $20.7M gain in Q3 2025) cut pre-tax income to $245.6M from $170.3M.
  • · Operating cash flow for 9M 2026 was $2,405.0M, up 47.0% from $1,635.7M, while capital expenditures rose modestly to $1,097.3M from $1,044.8M.
  • · Stockholders' equity increased to $8,266.6M from $8,080.0M, supported by retained earnings growth to $2,639.0M, while treasury stock rose to $1,731.3M from $1,304.1M.
  • · Total liabilities rose to $5,704.7M from $4,994.3M, driven by a $163.5M current derivative liability and higher revenues and production taxes payable.
  • · Accounts receivable rose 29.7% to $1,448.2M from $1,116.7M, absorbing $360.3M of operating cash in 9M 2026.
  • · Derivative instruments moved from a $77.3M current asset at December 31, 2025 to a $163.5M current liability at September 30, 2026.
  • · Assets held for sale totaled $444.4M in current assets and $52.9M in liabilities at September 30, 2026, with a $55.0M deposit received tied to the disposition.
  • · Net cash used in financing activities was $(644.3)M in 9M 2026, versus a $7.0M inflow in 9M 2025, as the company repaid no senior notes and repurchased $418.7M of common stock.
  • · Impairment and exploration expense fell 98.7% to $7.3M for 9M 2026 from $546.0M in 9M 2025, when a large impairment charge was recorded.
  • · Income tax expense for 9M 2026 was $211.9M, up 26.4% from $167.6M, while cash paid for income taxes rose to $119.2M from $73.1M.
Envoy Medical, Inc. 10-Q mixed materiality 6/10

05-11-2026

Envoy Medical (COCHW) reported Q3 2026 net revenues of $66K, up 57% from $42K in Q3 2025, but nine-month revenues of $156K fell 6% from $166K. Net loss narrowed to $3.9M in the quarter from $6.5M a year earlier, helped by a $1.2M non-cash warrant fair-value gain, while nine-month operating loss widened to $17.1M from $15.4M as R&D rose 24%. Cash increased to $14.6M from $3.7M at year-end 2025 following a February 2026 equity offering, and the stockholders' deficit narrowed to $(1.5)M from $(12.2)M.

  • · Sales and marketing expense fell 55% over nine months ($1.12M to $0.50M), a key driver of the improved cost structure despite higher R&D
  • · Cumulative Series A Preferred dividends of $3.95M for nine months were accrued but unpaid, adding to pressure on common stockholders' loss per share
  • · Accounts payable declined $1.35M in nine months, while accrued expenses rose to $11.6M from $7.6M, indicating reliance on deferred payments
  • · Net cash used in operations was $16.5M for nine months, versus $12.5M a year earlier, despite the cash balance rising on financing
  • · Accumulated deficit reached $331.6M, and Q3 revenue was only $66K, indicating the company remains pre-commercial in scale
  • · Interest expense to related parties was eliminated after the 2025 extinguishment of Term Loans, removing $1.59M of nine-month interest cost
ACM Research, Inc. 8-K mixed materiality 8/10

05-11-2026

ACM Research reported Q3 2026 revenue of $367.7 million, up 36.6% year over year, with shipments of $343.5 million (+30.6%). Non-GAAP operating income rose to $66.2 million from $36.5 million, but GAAP net income attributable to ACM fell sharply to $1.5 million from $35.9 million, driven by a $39.1 million unrealized loss on short-term investments versus an $18.7 million gain a year earlier; gross margin also slipped to 41.5% from 42.0%, below the company's 42%-48% long-term target. The company raised its FY2026 revenue outlook to $1.24-$1.28 billion from $1.125-$1.175 billion.

  • · Single-Wafer Hot SPM system achieves a 70% sulfuric acid recycle rate, saving approximately 400 tons of acid per tool annually
  • · Shipped first 310×310 mm panel-level ECP tool to an Asian customer in October, following a 515×510 mm R&D tool shipped last year
  • · Second building of Lingang facility expected online in Q4, doubling manufacturing floor space
  • · FY2026 guidance raise reflects strong demand but is contingent on trade policy, customer spending scenarios, supply chain constraints and first-tool acceptance timing
  • · Operating expenses as a share of revenue fell to 26.3% from 31.3%, while non-GAAP operating expenses rose 12.7%
  • · Net cash declined to $0.9B from $1.0B quarter over quarter, and total cash and deposits fell to $1.28B from $1.36B
Lantheus Holdings, Inc. 8-K mixed materiality 9/10

05-11-2026

Lantheus reported Q3 2026 worldwide revenue of $389.9 million, up 1.5% YoY, while GAAP net income fell 19.4% to $22.4 million and GAAP fully diluted EPS declined 19.5% to $0.33; adjusted EPS rose 32.3% to $1.68. Growth was mixed by product: PYLARIFY sales fell 0.7% to $238.9 million, while Neuraceq rose 123.0% to $45.6 million and DEFINITY rose 4.8% to $85.7 million. The company is suspending full-year 2026 guidance and skipping a conference call due to its pending all-cash merger with Curium at up to $114.50 per share (~$8.0 billion total transaction value).

  • · Lantheus suspended its full-year 2026 financial guidance and will not host a Q3 2026 earnings conference call due to the pending Curium merger.
  • · CMS granted Transitional Pass-Through status and a permanent HCPCS code for PYLARIFY TruVu, effective October 1, 2026.
  • · FDA approved TAUKLARIFY on August 14, 2026 for evaluating adults with cognitive impairment being assessed for Alzheimer's disease.
  • · FDA granted final approval to BRAVNETSA on September 22, 2026; the company describes it as the only radiopharmaceutical FDA-determined bioequivalent to LUTATHERA.
  • · The FTC extended the Hart-Scott-Rodino waiting period on October 21, 2026; closing still requires other antitrust and foreign direct investment approvals.
  • · The SPARROW Phase 3 portion of LNTH-2401 is expected to enroll approximately 400 participants.
  • · The FDA issued a Complete Response Letter for LNTH-2501 on June 26, 2026, citing unresolved third-party facility inspection conditions.
  • · Actions have been filed against the company by alleged stockholders relating to the merger.
LSI INDUSTRIES INC 8-K mixed materiality 7/10

05-11-2026

LSI Industries reported fiscal Q1 2027 (quarter ended September 30, 2026) net sales of $225.9 million, up 44% year-over-year, driven largely by the March 2026 Royston Group acquisition. Excluding Royston, net sales declined 2% amid softness in North American non-residential lighting, and the Lighting segment sales fell 6%. Net income was $7.1 million ($0.19 diluted EPS), adjusted net income $11.6 million ($0.31 adjusted diluted EPS), adjusted EBITDA $22.2 million (up 41%), and free cash flow $13.8 million; the company also declared a $0.05 quarterly dividend.

  • · Lighting segment declines spanned parking, small retail, warehouse, and automotive, partly offset by growth in refueling, sports, and banking
  • · QSR vertical demand remained soft, though a large QSR customer approved a 3,000-store interior renovation program starting late fiscal Q3 2027
  • · Management flagged customer project delays, delayed site releases, and changes to delivery/installation requirements ahead of the seasonal holiday slowdown
  • · Lighting segment gross margin improved despite lower volumes due to price actions against cost inflation; book-to-bill steady at 1.0
  • · Royston adjusted EBITDA margin expanded 100 basis points sequentially from fiscal Q4 2026
  • · Management cited cost inflation and elevated interest rates as potential headwinds for non-residential construction
  • · Net debt to proforma TTM adjusted EBITDA ratio was 2.6x at September 30, 2026
  • · Net income and adjusted net income figures are reported on a per-share basis of $0.19 and $0.31 respectively
Dyne Therapeutics, Inc. 10-Q mixed materiality 8/10

05-11-2026

Dyne Therapeutics reported a Q3 2026 net loss of $193.6 million ($1.06 per share), up from a $108.0 million loss ($0.76 per share) in Q3 2025, a 79% increase. Operating expenses rose to $197.1 million from $113.9 million, driven by R&D of $161.7 million (up 66%) and G&A of $35.3 million (up 112%). Cash, cash equivalents and marketable securities totaled roughly $1.13 billion at September 30, 2026, supported by a $404.9 million public offering in Q3, though net cash used in operations for the nine months reached $452.7 million.

  • · Q3 2026 interest expense rose about 105% to $5.9M from $2.9M, reflecting higher long-term debt ($200.0M vs. $148.9M at year-end 2025).
  • · Property and equipment, net fell to $7.1M from $24.0M at December 31, 2025, a decline of about 70%.
  • · Accumulated other comprehensive position swung from a $0.5M gain to a $1.0M loss, reflecting unrealized losses on marketable securities.
  • · Accumulated deficit reached $1.89B at September 30, 2026, up from $1.40B at year-end 2025.
  • · Cash, cash equivalents and marketable securities combined (about $1.13B) were broadly stable versus year-end 2025 (about $1.11B), with the Q3 equity raise offsetting cash burn.
  • · Q1 2026 and Q2 2026 quarterly net losses were $120.9M and $178.6M, showing a steadily accelerating loss trajectory through the year.
AGENUS INC 8-K mixed materiality 7/10

05-11-2026

Agenus reported Q3 2026 total revenue of $31.5 million (vs. $30.2 million in Q3 2025), including $6.0 million in pre-commercial BOT+BAL product revenue, which declined from $6.4 million in Q2 2026, and $25.5 million in non-cash royalty revenue, down from $28.1 million in Q2. Operating income was $11.4 million, the third consecutive positive quarter, while net income was $2.8 million for the quarter and $41.4 million year-to-date. Cash, equivalents and short-term investments rose to $86.9 million from $18.7 million at June 30, 2026, following an approximately $85 million upfront private placement, with up to approximately $255 million more available via milestone-aligned warrants.

  • · Armenia's Ministry of Health granted the first marketing authorizations for BOT and BAL anywhere in the world, for MSS metastatic colorectal cancer without active liver metastases.
  • · Upfront private placement proceeds expected to fund operations through Q3 2027; with full warrant exercise, funding extends through year-end 2031.
  • · Cash, equivalents and short-term investments remain well below the $255M warrant upside, which depends on milestones (60-patient enrollment in Q2 2027; interim pathologic response assessment in H2 2027).
  • · Operating income of $11.4M in Q3 2026 is down from $15.1M in Q1 2026 and $11.3M in Q2 2026 is roughly flat, indicating the trend is not uniformly improving.
  • · Net income of $2.8M in Q3 2026 declined from $39.2M in Q1 2026, which included a large non-operating benefit.
  • · Non-cash royalty revenue, which does not generate cash, made up about 81% of Q3 2026 total revenue ($25.5M of $31.5M).
  • · Service and other revenue was nil in 2026 versus $1.1M in Q3 2025 and $2.5M YTD 2025.
Priority Technology Holdings, Inc. 8-K mixed materiality 8/10

05-11-2026

Priority Technology Holdings (PRTH) reported Q3 2026 revenue of $268.6M, up 11.3% YoY (organic growth 9.2%), with adjusted EBITDA up 5.5% to $60.9M and adjusted diluted EPS up 7.1% to $0.30. However, GAAP net income fell 55.7% to $12.2M, diluted EPS fell 58.8% to $0.14, gross profit margin declined about 110 bps to 36.1%, and operating income dipped 5.0% to $35.9M. The company is being taken private by WD Capital Partners affiliates at $8.05 per share in cash, with closing expected in the first half of 2027, and it will not provide guidance or host an earnings call.

  • · Q3 2026 adjusted gross profit margin fell about 100 bps to 38.2%, and nine-month adjusted gross margin was 38.6% vs 38.9%
  • · Q3 2026 net income was depressed by a prior-year $21.2M deferred tax valuation allowance release absent in 2026 and $12.5M of debt extinguishment costs in Q3 2025, which do not recur
  • · Q3 2026 income tax expense was $4.4M versus a $20.2M benefit in Q3 2025
  • · Nine-month 2026 revenue was $780.4M (up from $705.9M) and nine-month net income was $31.8M (down from $46.7M)
  • · Transaction expected to close in first half of 2027, subject to stockholder approval and regulatory approvals; no earnings call or forward guidance will be provided
Flagship Private Wealth, LLC 13F-HR neutral materiality 4/10

05-11-2026

Flagship Private Wealth, LLC (Woburn, MA; CIK 0001842560) filed a Form 13F-HR on November 5, 2026, reporting equity holdings as of September 30, 2026, with 112 other included managers and a reported total portfolio value of approximately $284.7 billion across the information table. The portfolio is dominated by broad-market and index-based exchange-traded funds, led by iShares Core S&P 500 ETF, Invesco QQQ Trust, and iShares Global 100 ETF. The filing contains no period-over-period comparison data, so no prior-quarter performance changes can be assessed from this document alone.

  • · Holdings are reported entirely as sole investment discretion (SOLE) with no shared or other-manager discretion, and no voting authority breakdown is included in the summary table.
  • · Position concentration is heavily weighted toward passive/index ETFs, with the top ten positions by market value accounting for a large majority of the reported portfolio.
  • · The portfolio includes a small number of individual equity positions (e.g., Apple, Microsoft, NVIDIA, Alphabet, Amazon), which are minor relative to ETF holdings.
  • · One PureCycle Technologies entry is listed as a Call option (9,500 shares), indicating use of options alongside the common stock position in the same issuer.
  • · Small-cap and speculative positions such as Eos Energy Enterprises, Butterfly Network, and Quantum-Si are present but represent a very small share of total value.
Holley Inc. 10-Q mixed materiality 6/10

05-11-2026

Holley Inc. reported Q3 FY2026 (thirteen weeks ended September 27, 2026) net sales of $141.6M, up 2.3% from $138.4M in the prior-year quarter, with net income of $7.8M versus a net loss of $0.8M a year earlier. Results were mixed: nine-month net sales rose 0.6% to $460.9M and net income slipped 1.7% to $12.7M, while operating income for the nine months fell 36.5% to $39.8M, driven by a $28.6M loss on sale of assets.

  • · Gross margin expanded to 44.0% in Q3 FY2026 from 43.2% a year earlier, but nine-month gross profit was essentially flat at $193.5M.
  • · Nine-month SG&A rose 5.4% to $108.7M, and restructuring costs more than doubled to $4.5M from $2.2M.
  • · Interest expense fell 31.3% for the nine months to $27.7M from $40.3M, supporting bottom-line results despite lower operating income.
  • · Nine-month operating cash flow rose 45.6% to $58.3M from $40.1M, while capex increased 50.0% to $14.9M.
  • · Inventories fell to $181.6M from $205.7M at year-end 2025, a 11.7% reduction that contributed to cash generation.
  • · Accounts payable outflow of $15.5M and principal debt repayments of $28.3M (up from $18.6M) were notable cash uses.
  • · Nine-month foreign currency translation turned negative at $(2.6)M versus a $1.3M gain a year earlier.
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 13F-HR neutral materiality 4/10

05-11-2026

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group filed a Form 13F-HR holdings report for the quarter ended September 30, 2026, disclosing 32 long equity positions with an aggregate reported market value of approximately $465.8 billion on the cover page field (465768228 in thousands would be $465.8 million, so the reported total is best read as $465,768,228 thousand). The largest positions by value are Microsoft (about $47.8 million), NVIDIA (about $44.3 million), and Micron Technology (about $41.0 million), with most holdings held as sole investment discretion. Note that the cover page total does not reconcile cleanly with the sum of the listed positions, which is far smaller, so the figure should be verified against the source before use.

  • · Filing covers the quarter ended September 30, 2026 and was filed November 5, 2026 under Form 13F-HR.
  • · All 32 positions are reported with sole investment discretion and no shared or other-manager discretion.
  • · Portfolio is concentrated in large-cap technology and semiconductor names, with smaller positions in biotech (Arvinas, C4 Therapeutics, Nurix, Neurocrine, Syndax) and mining/energy (Barrick, Freeport-McMoRan, Pan American Silver, ConocoPhillips, Baker Hughes).
  • · Largest single line item by share count is Paymentus Holdings at 524,108 shares; largest by value among listed positions is Microsoft.
  • · Data-quality caveat: the cover page aggregate (465,768,228 in thousands) is orders of magnitude larger than the sum of the information table (roughly $0.9 billion), suggesting a reporting or units error to verify.
NATIONAL FUEL GAS CO 8-K mixed materiality 8/10

05-11-2026

National Fuel Gas reported fiscal 2026 full-year adjusted EPS of $7.55, up 9% from $6.91, and GAAP EPS of $7.02 versus $5.68. Fourth-quarter results were mixed: GAAP EPS fell to $1.02 from $1.18, while adjusted EPS was flat at $1.22, with Pipeline & Storage GAAP earnings down $1.7 million year over year. The company also closed the Ohio gas utility acquisition, announced a plan to spin off its Integrated Upstream and Gathering business as Seneca Resources in the second half of calendar 2027, and initiated fiscal 2027 adjusted EPS guidance of $6.00 to $6.40.

  • · Q4 Pipeline & Storage GAAP earnings fell $1.7M despite higher revenues, due to higher O&M and DD&A expense.
  • · Seneca Q4 production declined 7% to 104 Bcf as natural declines offset new well contributions.
  • · Seneca Q4 total operating costs per Mcf rose $0.12 to $1.39, driven by higher LOE and DD&A.
  • · FY2027 guidance assumes NYMEX gas at $2.85/MMBtu; adjusted EPS ranges from $5.60-$6.00 at $2.50 to $6.85-$7.25 at $3.50.
  • · FY2027 IUG production guidance of 400 to 435 Bcf incorporates estimated price-related marketing curtailments in October.
  • · Honeoye Storage Corporation was acquired October 30, 2026 and is excluded from Pipeline & Storage results.
  • · Tioga Pathway and Shippingport Lateral projects were placed in service November 1, 2026.
Playtika Holding Corp. 10-Q mixed materiality 7/10

05-11-2026

Playtika reported Q3 2026 revenues of $673.8M, roughly flat versus $674.6M in Q3 2025 (-0.1%), while nine-month revenues grew 3.5% to $2,149.6M from $2,076.6M. Q3 net income was $40.4M versus $39.1M a year earlier (+3.3%), but nine-month net income fell 70.0% to $30.9M from $102.9M, driven by a $177.0M change in contingent consideration and a $132.0M increase in G&A expense. Stockholders' deficit narrowed to $(358.3)M from $(411.4)M at year-end 2025, and cash and short-term investments declined to $594.6M from $820.2M.

  • · Nine-month 2026 cash flow from operations fell 20.4% to $224.4M from $281.8M.
  • · Nine-month accumulated deficit improved to $(1,220.3)M from $(1,251.2)M, supported by 2026 net income and no dividends declared in 2026.
  • · Current contingent consideration fell to $320.0M from $454.0M, with $350.0M paid in the nine months.
  • · Long-term debt was essentially stable at $2,370.3M versus $2,378.0M at year-end 2025.
  • · Net cash from investing rose to $69.0M from a $(115.8)M outflow, driven by lower short-term investment purchases and higher proceeds.
  • · Q3 2026 provision for income taxes rose to $52.0M from $19.0M, compressing pre-tax income gains.
  • · Interest and other, net declined 13.3% for the nine months to $114.1M from $131.6M and fell 41.1% in Q3 to $23.8M from $40.3M.
SCANSOURCE, INC. 10-Q mixed materiality 8/10

05-11-2026

ScanSource, Inc. reported Q1 FY2027 (quarter ended September 30, 2026) net sales of $962.3 million, up 30.1% year over year from $739.7 million, driven by the Specialty Technology Solutions and Intelisys segments. However, profitability weakened sharply: operating income fell 52.2% to $12.4 million, net income declined 56.3% to $8.7 million, and diluted EPS dropped to $0.42 from $0.89. Operating cash flow was negative $42.3 million versus positive $23.2 million a year earlier, while the company completed $217.8 million in business acquisitions funded partly by $231.9 million of revolver borrowings.

  • · Interest expense rose to $3.1M from $1.9M, while interest income fell to $2.7M from $3.2M, compressing net financing income as the company drew on its revolver.
  • · Provision for doubtful accounts rose to $6.4M from $1.9M, a more than threefold increase.
  • · Gross margin compressed to roughly 12.2% from 14.5%, while SG&A rose 28.2% to $96.5M, outpacing sales growth.
  • · Goodwill increased to $343.9M from $244.9M and identifiable intangibles rose to $237.0M from $64.4M, reflecting the acquisitions completed in the quarter.
  • · Total liabilities rose to $1,317.4M from $1,021.6M, while cash fell to $45.9M from $88.4M.
  • · Accounts receivable increased to $815.3M and inventories to $547.8M, consuming working capital and contributing to the operating cash outflow.
  • · Total shareholders' equity was essentially flat, rising only 0.5% to $915.7M, as the net income gain was largely offset by stock repurchases and tax settlements.
MACERICH CO 10-Q mixed materiality 8/10

05-11-2026

Macerich reported a Q3 2026 net loss attributable to the Company of $16.7 million ($0.06 per share), narrowing from a $87.4 million loss ($0.34 per share) in Q3 2025, while total revenues rose 2.7% year-over-year to $260.1 million. For the nine months, revenues were essentially flat (down 0.2% to $751.3 million) and the net loss attributable to the Company was $80.2 million versus $178.4 million a year earlier, with the improvement driven largely by prior-year impairments/losses on asset sales not recurring. Balance sheet strengthened through a large equity raise and refinancing activity, though leverage-related and interest costs remain significant.

  • · Nine-month net cash provided by operating activities fell 6.5% to $253.7M from $271.4M, a declining cash generation trend despite higher revenue base stability
  • · Management Companies' operating expenses rose 11.3% in Q3 2026 to $23.5M, and leasing expenses rose 46.6% in Q3 2026 to $15.6M, outpacing revenue growth
  • · Equity in income of unconsolidated joint ventures swung to a $8.1M loss for nine months 2026 from $8.5M income in 2025; Q3 2026 JV income also declined 28.1% to $7.0M
  • · Accumulated deficit widened to $4.0B at September 30, 2026 from $3.8B at December 31, 2025
  • · Loss on extinguishment of debt of $10.4M recognized in Q3 2026, with no comparable charge in the prior year
  • · Mortgage notes payable declined about $659M while bank and other notes payable of $758M were newly established, indicating a refinancing shift toward bank debt
  • · Q3 2026 distributions of $0.17 per share totaled $48.3M, unchanged in per-share terms from the level reflected in the filing context
  • · Nine-month cash, cash equivalents and restricted cash rose to $623.1M from $380.6M prior year, supported by $530.2M of stock offering proceeds
MARKETWISE, INC. 10-Q mixed materiality 6/10

05-11-2026

MarketWise, Inc. reported Q3 2026 total net revenue of $80.1M, down 1.4% YoY from $81.3M, and nine-month revenue of $232.9M, down 4.8% from $244.7M. Income from operations fell 10.8% YoY to $15.9M in Q3 and 78.7% for the nine months to $10.5M, driven by sharply higher sales and marketing expense ($115.4M vs. $96.9M for nine months). Net income attributable to MarketWise rose to $1.5M in Q3 but was roughly flat-to-up modestly versus $1.5M, while nine-month attributable net income declined to $0.3M from $3.7M; stockholders' deficit widened to $(263.7)M from $(213.6)M.

  • · Net cash provided by operating activities rose to $28.2M for nine months 2026 from $21.7M, while cash fell to $27.4M from $70.1M at year-end 2025 due to $68.9M of financing outflows including $37.9M in tax distributions to noncontrolling interests
  • · Deferred revenue and other contract liabilities (current plus noncurrent) totaled $386.6M, up from $369.6M at year-end 2025
  • · Noncontrolling interest deficit widened to $(229.2)M from $(201.9)M
  • · A $12.2M stock repurchase and TRA liability reduction was executed as part of a legal settlement during nine months 2026
  • · Subscriptions represented $79.5M of Q3 2026 revenue, with related-party revenue share declining to $0.2M from $0.4M
CION Investment Corp 8-K mixed materiality 7/10

05-11-2026

CION Investment Corporation reported Q3 2026 net investment income of $0.25 per share and a net loss per share of $(0.07), versus $0.62 in Q2, as NAV per share fell 2.7% to $13.20 from $13.57. Management cut balance sheet debt from $1.17 billion to $897 million and reduced net debt-to-equity to 1.30x from 1.52x, but results were weighed down by realized losses, lower total investment income, higher operating expenses, and rising non-accrual investments (1.63% of fair value, up from 1.44%). Sentiment is mixed: deleveraging progress and a declared Q1 2027 distribution of $0.25 per share sit alongside weaker earnings and asset quality.

  • · Q1 2027 base distributions declared totaling $0.25 per share, payable $0.08 (Jan 29), $0.08 (Feb 26), and $0.09 (Mar 26, 2027)
  • · Net realized losses of $9.2M in Q3 were attributed to restructuring of certain investments; unrealized losses of $6.7M reflected mark-to-market price decreases
  • · Operating expense increase was driven by legal fees tied to an investment restructure and SLFP formation costs, partly offset by lower advisory fees
  • · Interest expense rose due to a write-off of unamortized debt issuance costs from repaying the JPM Credit Facility
  • · Total investment income declined partly due to a reduction of a legacy transaction fee whose collectability is not reasonably assured
  • · Combined weighted average interest rate on debt was 7.6% in Q3 2026
  • · Interest coverage fell to 1.82x from 1.87x while weighted average leverage rose to 5.17x from 5.07x, indicating slightly weaker portfolio credit metrics
  • · Remaining capacity of $8M (2029 Notes) and $15M (2031 Notes) subject to purchaser acceptance before July 15, 2027
AEMETIS, INC 8-K mixed materiality 8/10

05-11-2026

Aemetis reported Q3 2026 revenue of $88.2 million, up 49% year over year, driven by $24.7 million of Section 45Z production tax credit income (including an approximately $11.0 million cumulative true-up tied to the September 8, 2026 45ZCF-GREET model update). Net income was $5.2 million, or $0.07 per basic share, versus a net loss of $23.7 million a year earlier, and Adjusted EBITDA was $24.8 million. However, quality of earnings is mixed: excluding the true-up and the bulk of the 45Z benefit, underlying profitability is weaker, interest expense remains high at $15.8 million, cash fell to $3.4 million, and year-to-date net loss was still $25.9 million with diluted EPS shown as $(0.02) against basic $0.07 in the same quarter.

  • · Excluding the ~$11.0M true-up, Section 45Z income for Q3 RNG was ~$9.1M, indicating a substantial portion of the quarter's headline revenue growth relies on a one-time catch-up adjustment.
  • · Diluted EPS was reported as $(0.02) versus basic EPS of $0.07 for Q3 2026, a divergence that should be reviewed against the full reconciliation.
  • · Cash declined to $3.4M from $4.9M at year-end 2025 despite the quarter's net income, and 9M operating cash flow was positive at $9.5M.
  • · Biodiesel sales fell about 47% YoY as India OMC shipments resumed only in late July 2026 under tender allocations.
  • · Series A Preferred Unit redemption date extended to December 31, 2026, with the default credit rate set at the greater of prime plus 5.0% or 12.0%.
  • · Capital projects of $35.3M were invested in 9M 2026, funded in part by $22.4M from the September 2026 sale of 45Z credits.
  • · Weighted average shares rose to 72.5M in Q3 2026 from 63.7M in Q3 2025, indicating dilution over the period.
Baird Medical Investment Holdings Ltd 6-K negative materiality 6/10

05-11-2026

Baird Medical Investment Holdings Limited (Nasdaq: BDMD) received a Nasdaq Listings Qualifications notice on November 2, 2026 that its ordinary shares closed below $1.00 for 30 consecutive business days, a deficiency under Nasdaq Listing Rule 5550(a)(2). The company has a 180-calendar-day compliance period until May 3, 2027 to regain compliance, with a possible additional 180-day period if it meets the other listing standards and submits a cure plan. Trading continues uninterrupted, and the company issued press releases on November 4, 2026 on the deficiency and on recent share price volatility.

  • · Nasdaq notice received November 2, 2026; shares continue trading under symbol BDMD with no immediate delisting
  • · Second 180-day period requires meeting market value of publicly held shares and other initial listing standards (excluding bid price) plus written notice and a proposed cure plan
  • · Press release on share price volatility issued November 4, 2026 (Exhibit 99.2)
  • · Filing incorporated by reference into Form F-3 shelf registration (No. 333-296153)
  • · Company files Form 20-F annual reports as a foreign private issuer
AEMETIS, INC 10-Q mixed materiality 8/10

05-11-2026

Aemetis reported Q3 2026 revenues of $88,153 thousand, up 48.9% YoY from $59,190 thousand, and swung to net income of $5,211 thousand versus a net loss of $23,747 thousand in the prior-year quarter. However, nine-month results remain loss-making with a net loss of $25,869 thousand (vs. $71,671 thousand a year earlier, an improvement), total stockholders' deficit widened to $314,207 thousand, and short-term debt obligations of $316,427 thousand plus short-term borrowings of $60,497 thousand far exceed cash of $3,359 thousand.

  • · Q3 2026 gross profit of $29,473 thousand (33.4% margin) contrasts with a near-breakeven gross loss of $(58) thousand in Q3 2025.
  • · Q3 2026 diluted EPS was $(0.02) despite basic EPS of $0.07, reflecting dilution from securities; nine-month basic and diluted EPS were both $(0.37).
  • · Current portion of long-term debt ($316,427 thousand) and short-term borrowings ($60,497 thousand) total $376,924 thousand, against a total current liabilities balance of $439,824 thousand and current assets of $29,128 thousand.
  • · Accumulated deficit reached $(665,812) thousand, and total liabilities and stockholders' deficit equal total assets of $311,995 thousand.
  • · Income tax benefit of $(129) thousand for nine months 2026 vs. a $(7,306) thousand benefit in nine months 2025.
  • · Cash paid for interest declined to $7,621 thousand (9M 2026) from $12,820 thousand (9M 2025), while accrued interest expense and fees rose $32,590 thousand in operating cash flows.
  • · Capital expenditures in accounts payable and accruals were $26,252 thousand, and accrued capital expenditures in construction financing were $6,286 thousand, signaling ongoing plant buildout obligations.
  • · Stock-based compensation was $4,018 thousand for nine months 2026 versus $4,976 thousand in 2025.
  • · Restricted cash fell to $1,518 thousand from $2,992 thousand, and the VIE holds $1,276 thousand of the $3,359 thousand in cash.
  • · Finished goods inventory surged to $7,389 thousand from $632 thousand, while raw materials dropped to $3,858 thousand from $9,593 thousand.
Ping An Biomedical Co., Ltd. 6-K neutral materiality 3/10

05-11-2026

Ping An Biomedical Co., Ltd. (Nasdaq: PASW) entered into a definitive patent purchase agreement on November 4, 2026 with Future Biotechnology Group Co., Limited to acquire three tumor cell-related medical technology patents for US$2.3 million, following a letter of intent dated October 22, 2026. The company describes the acquisition as a longer-horizon capacity-building move rather than a near-term revenue driver, and notes that closing remains subject to conditions and that negotiations on a proposed strategic investment in Future Biotechnology Group are still ongoing. No financial results or revenue figures were disclosed in the filing.

  • · The acquisition follows a letter of intent dated October 22, 2026
  • · Closing is subject to satisfaction of all closing conditions in the Purchase Agreement, and the company must complete registration procedures
  • · Post-acquisition, the company will evaluate patents via technical diligence and freedom-to-operate screening, with possible internal pilots, external partnerships, co-development, or outbound licensing
  • · Management explicitly states the acquisition is not a near-term revenue driver
  • · The company describes itself as a one-stop supply chain management service provider in the apparel industry, with healthcare and biomedical technology as a forward-looking focus
NOVAVAX INC 10-Q mixed materiality 8/10

05-11-2026

Novavax reported Q3 2026 total revenue of $68.3M, down 3.0% YoY from $70.4M, and a net loss of $31.4M versus a $202.4M loss in Q3 2025 (which included a $97.0M asset impairment and $28.7M debt extinguishment loss). For the nine months, revenue fell 72.9% YoY to $264.5M from $976.3M, and net loss was $94.3M versus net income of $422.8M a year earlier. Cash, cash equivalents, and marketable securities totaled $622.4M at September 30, 2026, down from $735.1M at year-end 2025, and stockholders' deficit widened to $216.9M.

  • · Product sales rose 91% YoY in Q3 2026 to $25.7M, while licensing, royalties, and other revenue fell 25% to $42.6M, indicating a shift in revenue mix
  • · Nine-month net cash used in operations was $199.5M, roughly flat versus $205.2M in the prior-year period
  • · Deferred revenue declined to $330.0M non-current and $102.2M current, down from $358.9M and $140.1M at year-end 2025
  • · Stockholders' deficit deepened to $216.9M from $127.8M at December 31, 2025, with accumulated other comprehensive loss increasing to $10.8M
  • · Long-term debt rose to $292.1M from $244.2M, supported by $46.4M in net credit facility proceeds in 2026
  • · Inventory increased 60% to $18.5M from $11.5M at year-end 2025
EQUITY RESIDENTIAL 8-K mixed materiality 9/10

05-11-2026

Vivmark Residential (NYSE: VMRK), formed by the August 17, 2026 merger of equals between Equity Residential (EQR) and AvalonBay Communities (AVB), reported Q3 2026 results showing a sharp GAAP swing (EPS of $(1.27) vs. $0.96 in Q3 2025, driven by $0.92 per share of Merger-related costs) alongside Core FFO per share up 5.1% to $1.03. Operating performance was mixed: Merged Same Store revenue rose 2.4% and NOI rose 1.7% in Q3, but physical occupancy slipped to 95.8% from 95.9% a year earlier, and FFO per share fell 92.6% to $0.08 and nine-month FFO per share fell 42.5% to $1.77.

  • · Merger accounted for as a reverse acquisition: AVB is the accounting acquirer, so historical financials are AVB's alone, while EQR's assets and liabilities were recorded at fair value as of August 17, 2026.
  • · Merged Same Store renewal rate achieved stood at 5.3% in Q3 2026, with new lease change improving from (3.4%) in Q1 2026 to 0.4% in Q3 2026 and blended rate rising to 3.1%.
  • · S&P Global Ratings raised the long-term issuer credit rating to 'A' (stable outlook) from 'A-' for both AVB and EQR on August 18, 2026.
  • · EQR communities are excluded from the Same Store Portfolio until January 1, 2028, so reported same-store growth reflects the stabilized merged basis rather than the formal Same Store Portfolio.
  • · Full Year 2026 Merged Same Store expense guidance includes approximately $16M of California property tax reassessment costs, with an estimated $50M annual impact beginning in 2027.
  • · Q4 2026 projected EPS guidance is negative at $(0.95) to $(0.91), while projected Core FFO per share is $1.01 to $1.05.
  • · Full run-rate synergies expected by March 2028, 18 months after the Merger Date.
  • · Q3 2026 Merged Same Store turnover improved to 12.7% from 13.2%, and year-to-date turnover improved to 31.8% from 32.8%.
ACADEMY CAPITAL MANAGEMENT 13F-HR neutral materiality 4/10

05-11-2026

ACADEMY CAPITAL MANAGEMENT (Waco, TX; CIK 0001031972) filed a Form 13F-HR on November 5, 2026 for the quarter ended September 30, 2026, reporting 38 holdings with an aggregate reported market value of $743,140,133 (approximately $743.1M). The portfolio is concentrated in large-cap technology and internet names, led by Alphabet (both share classes), Apple, Microsoft, Amazon, Meta, Taiwan Semiconductor, and Berkshire Hathaway. The filing contains no prior-period comparison, so no quarter-over-quarter change can be assessed from this document.

  • · Filer is based at 500 N. Valley Mills Drive, Suite 200, Waco, TX 76710; former name ACADEMY CAPITAL MANAGEMENT INC/TX.
  • · All 38 positions are reported as sole investment discretion with no shared or other-manager voting/investment authority.
  • · Top holdings by reported value are Apple (~$79.5M), Taiwan Semiconductor (~$66.9M), Alphabet Class C (~$65.8M), Amazon (~$60.3M), Microsoft (~$59.5M), and Meta (~$59.3M); together these represent a majority of the portfolio value.
  • · Smallest positions by value include Bausch Health (~$0.25M) and Chevron (~$0.36M), indicating a tail of small, low-weight holdings.
  • · Holdings include a mix of both Alphabet share classes (A and C) and Mobility Global Inc., a name that does not appear in standard large-cap indices and may warrant verification.
Holley Inc. 8-K mixed materiality 7/10

05-11-2026

Holley Performance Brands reported Q3 2026 net sales of $141.6 million, up 2.3% YoY (core business up 6.7% excluding divestitures), with net income of $7.8 million versus a $0.8 million loss last year. Adjusted EBITDA rose to $29.4 million (+8.6%) with margin expanding to 20.8%, and the company prepaid $25 million of debt, bringing leverage to 3.50x. However, year-to-date net sales grew only 0.6%, year-to-date net income declined 1.7%, operating income fell 36.5% YTD on $28.6 million of asset-sale losses, and management narrowed its full-year guidance citing a moderating consumer environment.

  • · Year-to-date operating income fell 36.5% to $39.8M, driven by a $28.6M loss on sale of assets
  • · Year-to-date net sales grew only 0.6% and net income declined 1.7%
  • · Year-to-date diluted EPS fell to $0.10 from $0.11
  • · Year-to-date SG&A rose 5.4% to $108.7M, offsetting cost-reduction gains
  • · Full-year guidance was narrowed (not raised), with management citing a conservative stance on the consumer environment
  • · Q3 2026 Operating Income of $19.6M versus $15.9M in Q3 2025 — a 23.3% increase, largely from lower R&D and interest expense
  • · Cumulative debt reduction of $125M since September 2023 with leverage at a four-year low of 3.50x
ONCOR ELECTRIC DELIVERY CO LLC 8-K mixed materiality 8/10

05-11-2026

Oncor reported Q3 2026 net income of $572 million, up from $380 million in Q3 2025 (+50.5%), and nine-month net income of $1,212 million versus $820 million (+47.8%), driven by new base rates effective June 1, 2026, higher UTM and SRP revenues, warmer-weather consumption, and customer growth. Operating revenues rose 24.5% to $2,296 million for the quarter, while operation and maintenance expense (+20.5%), depreciation (+18.7%), and interest expense (+29.9%) also increased, and the company is awaiting PUCT decisions on the Import Path 2 CCNs, the Wildfire Mitigation Plan, and ERCOT's December 2026 Batch Zero audit.

  • · Interest expense rose 29.9% in Q3 and 25.3% for nine months, a faster pace than revenue growth, which is relevant to earnings quality.
  • · Operating cash flow grew 58.7% YoY over nine months, but accounts receivable (-$474M) and inventories (-$372M) absorbed a large share of working capital.
  • · Customer deposits increased $693M in nine months (vs $53M in 2025), a material contributor to operating cash flow.
  • · Regulatory assets for UTM recovery grew $339M in nine months vs $55M prior year, indicating deferred recovery exposure.
  • · Batch Zero projects (about 24 GW classified as base load, 21 GW as studied load) remain outside the base capital plan until a final transmission plan in fall 2027.
  • · PUCT approval of the Import Path 1 CCNs is subject to pending rehearing motions and appeals; the Import Path 2 decision is still pending.
  • · Oncor plans to finalize its 2027-2031 capital plan in Q1 2027; the PUCT final decision on the Wildfire Mitigation Plan is expected in Q4 2026.
PERMA FIX ENVIRONMENTAL SERVICES INC 8-K mixed materiality 8/10

05-11-2026

Perma-Fix reported Q3 2026 revenue of approximately $17.9 million, up about 2% from $17.5 million a year earlier and up 39% sequentially, with the Services Segment up 46% YoY to $6.3 million and gross margin improving to 12.2%. However, Treatment Segment revenue fell to $11.6 million from $13.1 million, the Treatment Segment posted a gross loss of $225,000 (margin of (1.9%) versus 17.3% a year earlier), consolidated gross profit fell to $552,000 from $2.6 million, and the net loss widened to approximately $3.5 million ($0.16 per share) from $1.8 million ($0.10 per share). Management continues to disclose substantial doubt about the company's ability to continue as a going concern.

  • · Treatment Segment revenue decline was attributed to customer-directed changes in treatment protocols on a Hanford-related waste stream, with processing delayed until September 2026 and temporary downtime for thermal system upgrades.
  • · Treatment Segment gross margin fell to (1.9%) from 17.3%, driven by lower volumes and higher fixed operating costs spread over a smaller revenue base.
  • · Nine-month 2026 loss from continuing operations was $17.0M versus $7.8M in the prior-year period, and nine-month EBITDA was ($15.9M) versus ($7.0M).
  • · Nine-month 2026 Treatment Segment revenue was $27.8M versus $33.7M in 2025, and Treatment Segment gross loss was $5.7M for the nine months versus a gross profit of $4.1M a year earlier.
  • · PNC credit facility maturity was extended from May 2027 to May 2030 in August 2026.
  • · Management states substantial doubt about going concern has not been alleviated; execution depends on timing and volume of government-directed waste shipments and project activity.
  • · The $4.4B Master IDIQ ceiling is shared among three contract holders and does not represent amounts awarded to the Company; task order timing and size are uncertain.
  • · Gen 2.0 PFAS unit commissioning expected Q4 2026, with operations anticipated in 1H 2027; Florida legislation phasing out PFAS-containing firefighting foam is expected to support demand.
Belvedere Trading LLC 13F-HR neutral materiality 5/10

05-11-2026

Belvedere Trading LLC (Chicago, IL; CIK 0001632341) filed a Form 13F-HR for the quarter ended September 30, 2026, on November 5, 2026, disclosing its Section 13(f) equity and ETF holdings as of quarter-end. The information table lists the reported positions, which span common stock, ETF shares, and a large volume of call and put options, with the aggregate reported portfolio value stated as approximately $170.8 billion (170773880165 in thousands-of-dollars reporting convention as presented in the cover data). Because this is a holdings report rather than a financial results release, it does not contain period-over-period performance metrics for the filer; the position data is a point-in-time snapshot.

  • · Filing is a 13F-HR holdings report under Section 13(f) of the Exchange Act; SEC file number 028-16463; filer business address 10 S. Riverside Plaza, Suite 2100, Chicago, IL 60606
  • · The information table is dominated by call and put option positions across large-cap technology names (e.g., Advanced Micro Devices, Amazon, Apple, Broadcom) and single-stock leveraged ETFs, indicating substantial derivatives-based exposure
  • · Reported positions include crypto-linked exchange-traded products (Bitwise Bitcoin, Hyperliquid, Solana, and XRP ETFs; 21Shares Hyperliquid Staking) and commodity/equity-linked ETFs alongside single-name equities
  • · Cover page indicates an 'Other Included Managers' count of 1060, which is unusually high for a single filer and should be verified against the source XML
  • · Share counts and reported values in the table are presented as raw figures; the table includes values that appear inconsistent with typical per-share pricing for some positions (for example, a very large notional value on Amazon options), so the extracted dollar amounts should be cross-checked against the primary EDGAR document before any publication
ACI WORLDWIDE, INC. 10-Q mixed materiality 7/10

05-11-2026

ACI Worldwide's Q3 2026 10-Q shows total revenue of $426.8M for the quarter, down 11.5% from $482.4M in Q3 2025, and net income of $32.5M versus $91.3M a year earlier (down 64.3%). Nine-month revenue was essentially flat at $1,283.0M versus $1,278.2M (+0.4%), with SaaS/PaaS revenue up 6.6% while license revenue fell 17.0%. Operating income fell sharply to $52.4M for the quarter from $127.7M, and diluted EPS was $0.32 versus $0.88.

  • · Operating expenses rose 5.6% YoY in Q3 2026 to $374.4M, driven by a 9.7% increase in cost of revenue and a 17.8% increase in G&A.
  • · Other, net swung to a $1.1M expense in Q3 2026 from $1.6M income a year earlier, and nine-month other income fell from $18.9M to $1.1M, reflecting the absence of the 2025 equity investment gain of $25.9M.
  • · Income tax expense fell to $9.7M from $26.9M, with the effective tax rate at 22.9% for Q3 2026 versus 22.8% in Q3 2025.
  • · Total debt was reduced from the prior year-end, and revolver borrowings of $70M were drawn while $40M was repaid during the nine months.
  • · Settlement assets rose to $473.6M from $397.3M at year-end 2025, and accounts receivable declined to $428.3M from $445.9M.
Clear Harbor Asset Management, LLC 13F-HR neutral materiality 3/10

05-11-2026

Clear Harbor Asset Management, LLC filed a Form 13F-HR on November 5, 2026, reporting its institutional equity holdings as of September 30, 2026. The filing is a routine quarterly disclosure of long positions in Section 13(f) securities and does not, on its face, report a period-over-period comparison, deal, or regulatory action. The holdings table is extensive and concentrated in large-cap technology and industrial names, with the largest single positions including Apple, Alphabet, Amazon, and Berkshire Hathaway.

  • · Filing covers holdings as of September 30, 2026 (period of report 20260930), filed November 5, 2026.
  • · Filer is based in Stamford, CT; SEC file number 028-14126; signed by Ian Armstrong, Chief Operating Officer.
  • · The filing includes put and call option positions (e.g., Alphabet puts, Apple puts, Disney calls), indicating some derivatives exposure alongside common stock holdings.
  • · Several small-cap and speculative names appear in the table, including Allogene Therapeutics, Cabaletta Bio, Context Therapeutics, and Intellicheck Mobilisa, which may signal a diversified or specialty allocation.
  • · The excerpt provided is truncated mid-table, so the full holdings list and total entry count cannot be fully verified from this text.
  • · Monetary values in 13F filings are conventionally reported in thousands of dollars; the figures are reproduced here as stated in the source without re-scaling.
WATTS WATER TECHNOLOGIES INC 10-Q mixed materiality 8/10

05-11-2026

Watts Water Technologies reported strong third-quarter 2026 results, with net sales up 19.0% YoY to $728.0M and net income up 76.9% to $145.4M (diluted EPS $4.34 vs. $2.45). Nine-month net sales rose 19.6% to $2,168.4M and net income rose 41.3% to $363.3M. Results were not uniformly positive: SG&A grew faster than sales at 13.5% for the quarter, operating cash flow for the nine months was up only modestly (+12.8%), free cash flow was constrained by higher capex, and accumulated other comprehensive loss widened.

  • · Long-term debt was reduced by $100.0M (roughly 51%) during the nine months, from $197.7M to $98.2M.
  • · Cumulative accumulated goodwill impairment reached $167.1M, with Europe ($129.7M) and Americas ($24.5M) carrying most of it; goodwill net fell to $859.1M, with a $3.6M decline in the nine months (including $3.7M of Europe impairment-related reduction).
  • · Accounts receivable rose 35.8% to $399.3M since year-end, outpacing sales growth and consuming $109.0M of operating cash in the nine months.
  • · Capital expenditures rose 55.9% to $48.8M for the nine months, reducing free cash flow to roughly $230.1M versus $216.0M in the prior year (+6.5%), a smaller gain than net income growth.
  • · Accumulated other comprehensive loss widened to $(138.0)M from $(127.5)M, reversing much of the prior-year translation gain ($48.1M in 9M 2025 vs. $(9.9)M in 9M 2026).
  • · Dividends declared per share rose to $0.63 in Q3 (from $0.52), and nine-month dividends paid were $60.0M versus $49.4M.
  • · Share count was essentially flat at roughly 33.5M weighted average shares, so EPS growth is driven by earnings rather than buybacks ($11.8M repurchased for the nine months, unchanged YoY).
  • · Restructuring charges fell sharply to $6.1M for nine months from $22.6M, a 73% decline.
Occidental Asset Management, LLC 13F-HR neutral materiality 4/10

05-11-2026

Occidental Asset Management, LLC filed its Form 13F-HR for the quarter ended September 30, 2026, on November 5, 2026, disclosing 379 holdings in its Section 13(f) securities portfolio with a total reported value of approximately $1.16 billion (1,155,874,561 in thousands of dollars per the information table convention). The portfolio is heavily concentrated in ETFs and index-tracking vehicles, with large positions in Apple, Alphabet, Amazon, Advanced Micro Devices, and Dell Technologies among individual equities.

  • · Filing covers the quarter ended September 30, 2026, with signature dated November 4, 2026, and filing accepted November 5, 2026.
  • · Filer is a Burlingame, California-based asset manager with SEC file number 028-19444; the report lists 379 entries, all held with sole investment discretion and no shared or other-manager voting authority.
  • · Notable single-line positions include a Broadcom put option (200 contracts, $6.76M) indicating a hedged or options-based position alongside the common share holdings.
  • · Portfolio includes a substantial number of structured/buffer and dual-directional Innovator ETF positions, reflecting a derivatives-linked ETF allocation strategy.
  • · Exposure to income-oriented closed-end funds (abrdn, BlackRock municipal and technology funds) and municipal bond ETFs suggests a yield-focused component.
Mechanics Financial Corp 13F-HR neutral materiality 4/10

05-11-2026

Mechanics Financial Corp filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing equity holdings across roughly 290 positions with a reported total portfolio value of approximately $276.4 billion. Holdings are dominated by large-cap technology and index-tracking ETFs, led by Apple, Microsoft, Nvidia, and JPMorgan Chase, while a number of smaller and legacy positions show modest or no meaningful exposure.

  • · Filer is headquartered in Mansfield, Ohio (2 South Main Street); state of incorporation Ohio; fiscal year end September 30
  • · Filing reports 291 holdings with 'Other Included Managers' count of 0 and 'Other Managers' count of 0 on the cover page
  • · Gorman Rupp Co. shows an unusually large reported value (~$21.8B) relative to its share count, which may reflect a data entry or unit issue and warrants verification against the source filing
  • · Portfolio includes a notable allocation to ETFs spanning broad-market, international, emerging markets, fixed income, commodities, and crypto (iShares Bitcoin Trust)
  • · Discretion is reported as sole (DFND) for all positions, with voting authority split across sole, shared, and none columns
NorthWestern Energy Group, Inc. 8-K mixed materiality 8/10

05-11-2026

NorthWestern Energy reported Q3 2026 GAAP diluted EPS of $0.50 versus $0.62 in Q3 2025, and non-GAAP diluted EPS of $0.58 versus $0.79, with net income of $30.7 million versus $38.2 million. The decline was driven by a $6.1 million net loss tied to additional Colstrip Units 3 and 4 interests, higher depreciation and interest expense, partly offset by lower non-recoverable Montana supply costs, retail volumes, transmission revenue and merger costs. The company affirmed 2026 non-GAAP EPS guidance of $3.68-$3.83, the $683 million 2026 capital plan, its 4%-6% long-term EPS growth rate, and declared a $0.67 quarterly dividend, while the pending all-stock merger with Black Hills is expected to close by year-end 2026 pending Montana PSC approval.

  • · Sabey Data Centers development agreement has been terminated, leaving a reduced data center pipeline tied to Atlas and Quantica.
  • · Montana PSC decision on the merger is expected before November 12, 2026, and the MPSC has not set settlement or hearing dates for the LNL Rule.
  • · Affirmed 2026 guidance assumes normal weather, excludes merger costs, and depends on PCCAM waiver approval and sufficient power prices to recover Avista and Puget Colstrip costs.
  • · Designated Avista power sales contracts failed to cover Avista Interest O&M costs in Q3 2026, indicating the PCCAM waiver is not yet providing offsetting recovery.
  • · Puget Colstrip interests are held by a FERC-regulated subsidiary; an appeal by two MPSC commissioners is pending at the Ninth Circuit, with the case in abeyance until December 11, 2026.
  • · Equity issuances are expected beginning in 2027 to fund South Dakota generation investment.
  • · Dividend record and payment dates were revised from December 15 and December 31, 2026 to November 17 and December 1, 2026 due to the merger; if the merger closes first, shareholders may receive a $0.703 Bright Horizon dividend instead.
  • · SPP updated resource accreditation and planning reserve margin requirements, a potential future factor for South Dakota resource planning.
Fund Evaluation Group, LLC 13F-HR neutral materiality 3/10

05-11-2026

Fund Evaluation Group, LLC (Cincinnati, OH; SEC file no. 028-11872) filed a Form 13F-HR on November 5, 2026 reporting its equity holdings as of September 30, 2026. The filing lists approximately 86 positions, all of them ETFs or ETF-like funds, with a reported aggregate value of about $4.22 billion ($4221816606 in the filing's value field). The filing contains only current-period holdings, so no period-over-period comparison can be made.

  • · The portfolio is concentrated in broad-market, index-style and fixed-income ETFs, with a notable allocation to Treasury and short-term bond funds.
  • · Two Schwab-branded line items appear under similar names ('Schwab International Equity ETF' and 'Schwab U.S. Large-Cap Growth ETF') alongside separately listed Schwab ETFs, which may reflect naming variations in the filer's reporting.
  • · Blue Owl Technology Finance Corp (1,113,199 shares) and Caris Life Sciences Inc (48,923 shares) are the only operating-company common stock positions; the remainder are exchange-traded funds.
  • · The filing reports sole investment discretion (SOLE) for all positions, with no shared or other-manager discretion disclosed.
  • · The filing covers 2 public documents and is filed under the 13F-HR form type with an effectiveness date of November 5, 2026.
BLUEDOOR PRIVATE WEALTH, LLC 13F-HR neutral materiality 4/10

05-11-2026

BLUEDOOR PRIVATE WEALTH, LLC (Beverly, MA) filed a Form 13F-HR on November 5, 2026 reporting its equity and fund holdings as of September 30, 2026. The filing lists 163 positions with a total reported portfolio value of approximately $235.8 billion (235,802,147 in thousands of dollars), concentrated in broad-market ETFs, mega-cap technology names, and index-tracking funds. The filing contains no period-over-period comparison, so no performance change can be assessed from this document alone.

  • · Filer is a Massachusetts-incorporated LLC with SEC file number 028-26402 and EIN 84-3403280, located at 50 Dunham Road, Suite 1250, Beverly, MA 01915
  • · Report covers holdings as of September 30, 2026; filed November 5, 2026, with 2 public documents in the submission
  • · Portfolio is heavily weighted toward ETFs and index-tracking funds, with a large share of positions held via ETF shares rather than individual stocks
  • · Largest ETF-type exposures by value include J.P. Morgan Ultra Short ETF (~$13.15B), Vanguard Morningstar Growth ETF (~$6.57B), and iShares Core S&P Mid-Cap ETF (~$6.12B)
  • · Individual equity exposure is led by Apple (~$9.64B), Amazon (~$6.33B), Alphabet Class A and C combined (~$8.19B), Berkshire Hathaway Class B (~$7.02B), and Microsoft (~$6.17B)
  • · The filing contains no prior-period figures, so quarter-over-quarter or year-over-year changes in holdings cannot be determined from this document
RALPH LAUREN CORP 10-Q mixed materiality 8/10

05-11-2026

Ralph Lauren reported Q2 FY2027 (quarter ended September 26, 2026) net revenues of $2,193.3 million, up 9.1% YoY from $2,010.7 million, with net income rising 42.9% to $296.6 million and diluted EPS up to $4.87 from $3.32. Growth was led by Retail (+11.8%) and Wholesale (+5.4%), while Licensing declined 9.0% and Asia Wholesale-adjacent momentum was mixed; SG&A grew faster than revenue (+10.9%), and restructuring charges rose 69.4% to $63.2 million. Six-month net revenues rose 11.3% to $4,153.1 million and operating cash flow improved sharply to $618.2 million from $229.3 million, though inventories grew 13.5% and cash fell 28.3% to $1,426.1 million as buybacks of $626.6 million exceeded free cash generation.

  • · Gross margin expanded to 74.2% in Q2 FY2027 from 68.0% in Q2 FY2026, driven by lower cost of goods sold ($565.4M vs $644.3M), partially offset by higher SG&A.
  • · Effective tax rate rose to 19.7% in Q2 FY2027 from 14.5% in Q2 FY2026 ($72.6M vs $35.3M tax provision), a headwind to net income growth.
  • · Asia revenues grew 28.2% YoY to $571.3M in Q2 FY2027, while North America grew 6.4% and Europe grew 1.1%.
  • · Six-month inventories rose $134.2M in operating cash flow, versus a $281.6M build in the prior year period, a relative improvement.
  • · Six-month share repurchases of $630.0M (equity statement) exceeded dividends of $118.7M declared, with treasury stock increasing to $8,991.9M.
  • · Total equity declined from $2,841.4M at March 28, 2026 to $2,729.8M at September 26, 2026 because buybacks outpaced retained earnings growth.
Inman Jager Wealth Management, LLC 13F-HR neutral materiality 2/10

05-11-2026

Inman Jager Wealth Management, LLC (Hattiesburg, MS) filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing equity and ETF holdings with a reported total portfolio value of $193,604,056 across 89 securities. The portfolio is concentrated in broad-market and international index ETFs (led by iShares Core S&P 500 ETF at $20,330,424 and iShares Core MSCI International at $4,855,037), with major single-stock positions in Microsoft ($23,695,980), Apple ($3,423,446), and Chevron ($3,970,251). The filing reports holdings only and contains no period-over-period comparison data.

  • · Filer is an SEC-registered investment manager (File No. 028-24623) based in Hattiesburg, Mississippi, with CIK 0002052044
  • · Portfolio is heavily weighted toward ETFs and index funds rather than individual stocks
  • · Largest single-stock position by value is Microsoft at approximately $23.7M, followed by Chevron at approximately $4.0M and Apple at approximately $3.4M
  • · Holdings are reported entirely as sole investment discretion (SOLE), with no shared or other-manager discretion reported
  • · The filing contains no prior-period comparison, so quarter-over-quarter changes in positions cannot be assessed from this document alone
Systelligence, LLC 13F-HR neutral materiality 3/10

05-11-2026

Systelligence, LLC (CIK 0001882691, Bloomington, MN) filed a Form 13F-HR on November 5, 2026, reporting its institutional equity holdings as of September 30, 2026. The report lists 57 positions, all held with sole investment discretion, and an aggregate reported value of approximately $604.9 million. The portfolio is concentrated in exchange-traded funds spanning equity, fixed income, commodity, and thematic strategies, with no individual disclosed holding appearing in the filing beyond the ETF positions listed.

  • · Portfolio is entirely ETF-based (no common stock or other direct equity positions listed) across 57 holdings
  • · Asset mix spans U.S. and international equity, Treasury and corporate bond, convertible bond, gold/silver/metals, uranium, and thematic (AI, semiconductors, infrastructure, defense) ETFs
  • · Filer is an investment adviser registered under Section 13(f) of the Securities Exchange Act of 1934 (SEC File No. 028-21370), filing as an institutional investment manager with Minnesota incorporation
  • · Reporting period ends September 30, 2026; filing submitted November 5, 2026 with contact via Overland Park, KS signatory office
Lottery.com Inc. 8-K positive materiality 4/10

05-11-2026

Sports Entertainment Gaming Global Corporation (Nasdaq: SEGG; the filing refers to the company as Lottery.com Inc. in the request) received a November 4, 2026 letter from Nasdaq's Office of the General Counsel confirming it has regained compliance with Listing Rule 5250(c)(1). As a result, the November 19, 2026 Nasdaq Hearings Panel hearing has been cancelled and the securities will continue to be listed and traded on Nasdaq. The company had filed its delayed Q2 2026 Form 10-Q on November 2, 2026, which cured the late-filing deficiency.

  • · Nasdaq Listing Rule 5250(c)(1) deficiency related to the late Form 10-Q for the quarter ended June 30, 2026
  • · Nasdaq Listing Qualifications Department deficiency letter dated October 14, 2026
  • · Hearing before the Nasdaq Hearings Panel originally scheduled for November 19, 2026 was cancelled
  • · Securities registered under Section 12(b): common stock, par value $0.001 per share, ticker SEGG, listed on The Nasdaq Stock Market LLC
  • · Company is an emerging growth company; filing also includes forward-looking statement cautions about future timely periodic reporting
ORMAT TECHNOLOGIES, INC. 10-Q mixed materiality 7/10

05-11-2026

Ormat Technologies reported Q3 2026 total revenues of $275.1 million, up 10.2% YoY from $249.7 million, driven by energy storage (+145.1% to $49.9 million) and product revenues (down 1.2% to $61.5 million). Net income attributable to stockholders rose 32.2% to $31.9 million, while electricity revenues declined 2.1% to $163.7 million and interest expense increased 23.9% to $44.2 million. For the nine months, total revenues rose 31.5% to $937.8 million and net income attributable to stockholders rose 11.4% to $103.1 million.

  • · Net cash provided by operating activities was flat (down 0.5%) at $228.9M for 9M 2026 versus $230.1M for 9M 2025, while capital expenditures fell 10.6% to $424.5M.
  • · Interest expense, net for 9M 2026 rose 24.6% to $133.1M, and non-operating expense included a $20.0M other non-operating loss versus a $0.4M gain in 9M 2025.
  • · Total convertible notes principal rose to $1,190.6M at Sept 30, 2026, with the 2031 Convertible Notes issued at $1,000.0M and $310.9M in 2027 notes prepaid; an induced conversion expense of $34.4M was recorded in 9M 2026.
  • · Income tax benefit for 9M 2026 was $31.9M versus $13.5M in 9M 2025, and deferred income tax provision was a $47.8M benefit versus $22.0M benefit prior year.
  • · Customer concentration declined: SCPPA fell from 17.9% to 13.4% of revenue (9M), Sierra Pacific/Nevada Power from 13.7% to 10.8%, and KPLC from 12.1% to 10.2%.
  • · Q3 2026 electricity revenue declined 2.1% YoY, and Q3 2026 operating income grew only 11.9% despite a 10.2% revenue increase, with G&A expenses up 15.4% to $23.3M.
  • · Acquisition activity: a business acquisition produced a $9.6M bargain purchase gain (cash consideration $79.3M), and a second acquisition produced $16.1M of goodwill ($72.6M net assets acquired).
  • · A power plant sale generated $93.1M of cash proceeds and a $24.8M gain in 9M 2026.
  • · Impairment of long-lived assets totaled $8.6M for 9M 2026 (versus none in 9M 2025), and write-offs of unsuccessful exploration and storage activities rose to $10.8M from $1.1M.
Brooklyn FI, LLC 13F-HR neutral materiality 3/10

05-11-2026

Brooklyn FI, LLC filed a Form 13F-HR on November 5, 2026, reporting its equity and fixed-income holdings as of September 30, 2026. The filing lists approximately 127 positions, dominated by ETFs and index funds, with a reported total portfolio value of $686,341,416 (approximately $686.3 million). Individual stock exposure is concentrated in mega-cap technology names such as Apple, Alphabet, Microsoft, and NVIDIA.

  • · Holdings are almost entirely ETF and index-fund exposure (e.g., Vanguard, iShares, Schwab, SPDR, Dimensional), with broad US equity, international equity, emerging markets, REITs, and municipal/fixed-income funds dominating by value.
  • · Largest reported individual position by value is the iShares TRS Flt Rt Bd ETF at approximately $28.5 million, followed by the Vanguard S&P 500 ETF at roughly $50.7 million; the latter is the largest single line item in the table.
  • · Direct single-stock positions are comparatively small, led by Apple (~$4.8M), Alphabet Class C (~$5.8M), Microsoft (~$3.6M), and NVIDIA (~$3.6M).
  • · Berkshire Hathaway Class A is held as 3 shares (~$2.6M), an unusually high per-share price exposure illustrating the Class A/B structure in the table.
Investment Management Trust, LLC 13F-HR neutral materiality 3/10

05-11-2026

Investment Management Trust, LLC (Fitchburg, MA; CIK 0002131759) filed its Form 13F-HR on November 5, 2026, reporting equity holdings as of September 30, 2026 across 77 securities with a total reported value of approximately $113,138,387 (in thousands-reported filings, the table value field is 113138387, consistent with roughly $113.1 billion if reported in thousands, or $113.1 million if reported in dollars; the filing's own unit convention should be confirmed against the primary document). Largest positions include NVIDIA, Apple, Alphabet (Class A), Microsoft, and Amazon, with broad exposure across ETFs and sector funds. The filing discloses no insider-style trading events or regulatory actions; it is a routine quarterly holdings disclosure.

  • · Filer is a Massachusetts LLC with SEC file number 028-26825 and IRS EIN 474338264.
  • · Holdings are reported as sole investment discretion (SOLE) with no shared or other-manager allocations.
  • · Portfolio is concentrated in mega-cap technology (NVIDIA, Apple, Alphabet, Microsoft, Amazon, Meta) alongside a significant allocation to dividend-focused and sector ETFs.
  • · Gold exposure via SPDR Gold Trust is among the larger non-equity-stock positions.
TELEFLEX INC 10-Q mixed materiality 8/10

05-11-2026

Teleflex reported Q3 2026 net revenues of $567.8M, up 0.2% YoY from $566.9M, with income from continuing operations of $54.3M versus a $58.4M loss a year earlier. Net income swung to $927.4M (vs. a $408.9M loss) driven almost entirely by $873.1M of income from discontinued operations, while nine-month net revenues rose 18.4% to $1,686.4M. Growth was flat at the top line for the quarter: Vascular grew 4.7% and Surgical 4.3%, but Interventional declined 2.6% YoY, and Rest of World revenue fell 0.8% (ex-Other), with North America up 0.9%.

  • · Interventional segment revenue declined 2.6% YoY in Q3 2026 and was the only segment to shrink in North America-plus-RoW aggregate terms
  • · Q3 2026 SG&A rose 6.4% YoY to $220.7M and R&D fell 2.9% to $43.0M
  • · Restructuring and impairment items were a $0.3M credit in Q3 2026 versus a $102.8M charge in Q3 2025, a major driver of the operating improvement
  • · Nine-month 2026 share repurchases totaled $555.0M in cash, while long-term borrowings fell from $2,541.4M to $1,531.5M after $3,368.1M of debt reductions
  • · Income taxes payable rose sharply to $194.6M from $18.8M at year-end 2025, a liquidity item worth monitoring
  • · Q3 2026 Other revenue of $9.0M in the prior year did not recur
First Bancorp, Inc /ME/ 10-Q mixed materiality 6/10

05-11-2026

First Bancorp, Inc /ME/ (FNLC) reported Q3 2026 net income of $10.7M ($0.96 basic EPS), up 17.5% from $9.1M ($0.82) a year earlier, with nine-month net income of $29.2M, up 20.7% YoY. Net interest income rose 12.2% YoY in the quarter to $22.5M, and total assets reached $3.25B. However, credit quality weakened: non-performing loans rose to 0.58% of total loans from 0.40%, and other comprehensive loss of $11.7M in the quarter (net unrealized losses on AFS securities) pushed comprehensive income to a $1.0M loss for the quarter.

  • · Dividends declared rose to $0.38 per share in Q3 2026 from $0.37, with a 39.62% payout ratio versus 45.18% a year earlier
  • · Non-interest expense growth (6.2% YoY in the quarter) was well below revenue growth, supporting the efficiency ratio improvement
  • · Deposit growth was driven by certificates of deposit ($1.05B, up 69.6M YTD) while demand deposits grew 13.2% YoY to $316.8M
  • · Mortgage origination and servicing income was essentially flat year-to-date ($603K vs $635K, down 5.0%)
  • · Nine-month credit loss expense rose 60.6% YoY to $2.5M, and provision for loans rose 68% in the quarter ($845K vs $690K)
  • · Total investment securities were flat YoY at $643.1M, with AFS securities up 3.4% YoY but HTM securities down 2.8%
  • · Repayment of $25.0M in long-term borrowings during the nine months, reducing long-term borrowings to $70.5M
Oak Barrel Wealth Advisory LLC 13F-HR neutral materiality 4/10

05-11-2026

Oak Barrel Wealth Advisory LLC (Reston, VA; SEC File No. 028-26861) filed its Form 13F-HR on November 5, 2026, reporting equity holdings as of September 30, 2026. The filing lists 84 positions with an aggregate reported market value of approximately $232.3 billion, dominated by ETF exposure. The filing shows no prior-period comparison, so period-over-period performance cannot be assessed from this document.

  • · Portfolio is heavily concentrated in ETFs, with ETF positions making up the large majority of reported value, including broad-market index funds, sector funds, international funds, bond ETFs, and crypto-linked ETFs.
  • · Direct single-stock holdings are comparatively small, led by Apple (~$5.68B), Alphabet Class A and C (~$1.87B and ~$1.78B), Amazon (~$2.71B), and Microsoft (~$3.99B).
  • · Crypto exposure is held through spot Bitcoin ETFs (iShares Bitcoin Trust ~$0.81B; Franklin Templeton Digital Holdings Bitcoin ETF ~$0.56B).
  • · All positions are reported with sole investment discretion (SOLE) and no shared or other-manager voting/investment authority.
  • · The filing covers the period ending September 30, 2026; no prior-quarter figures are included, so quarter-over-quarter changes cannot be determined.
REGIONS FINANCIAL CORP 13F-HR neutral materiality 2/10

05-11-2026

Regions Financial Corp (filer CIK 0001281761, filing agent Regions Bank with sub-managers Regions Investment Management, Inc. and Highland Associates Inc.) filed a Form 13F-HR on November 5, 2026 reporting its institutional equity holdings as of September 30, 2026. The filing is a routine quarterly disclosure of long positions in Section 13(f) securities and contains no material corporate, financial-performance, or regulatory development for Regions itself. Aggregate portfolio value is reported in the information table, though the table is truncated in the provided text and the full total is not verifiable here.

  • · Largest reported single positions in the visible portion of the table include Apple Inc (about 532,639 shares, roughly $177.4 billion reported value), Alphabet Class C and Class A, Amazon, Coca-Cola, and Berkshire Hathaway Class B, indicating a diversified large-cap equity and ETF book.
  • · Filing reports holdings with investment discretion 'DFND' (sole/defined) and no shared or other-manager allocations shown in the visible rows.
  • · Filing period is quarter ended September 30, 2026; accession number 0001281761-26-000067.
Federal Home Loan Bank of Atlanta 8-K neutral materiality 3/10

05-11-2026

The Federal Home Loan Bank of Atlanta filed an 8-K under Item 2.03 disclosing the creation of direct financial obligations through the issuance of consolidated obligation bonds, for which the Bank is primary obligor. Schedule A lists four callable fixed-rate bonds with trade dates of November 2 and 3, 2026, bank par amounts totaling $285,000,000 (two $150,000,000 and $15,000,000 tranches on November 2, and $100,000,000 and $20,000,000 tranches on November 3), coupons of 4.65% and 4.64%, and maturities in December 2027. The filing is routine funding disclosure and contains no information on earnings, credit quality, or adverse developments.

  • · All four bonds are Optional Principal Redemption (callable) bonds with Bermudan call style and fixed constant rate structure, with next call dates of February 9, 2027 (CUSIP 3130BCTA1) and February 4, 2027 (CUSIP 3130BCTH6).
  • · Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, backed only by their financial resources and not guaranteed by the U.S. government.
  • · Schedule A excludes discount notes with maturities of one year or less and does not reflect interest-rate derivatives, so it does not show total outstanding obligations.
Leapfrog Acquisition Corp 10-Q mixed materiality 5/10

05-11-2026

Leapfrog Acquisition Corp (LFAC), a blank-check SPAC, reported net income of $1,188,406 for the three months ended September 30, 2026 and $3,388,244 for the nine months, driven almost entirely by $1,303,187 and $3,813,404 of interest earned on its Trust Account. Operating costs rose sharply, with G&A expenses of $114,781 in the quarter (up from $54,875 a year earlier) and $425,160 year-to-date (versus $60,889 in the prior inception period), while the company carries a $4,101,351 shareholders' deficit and a $5,031,250 deferred underwriting fee. Trust Account value per redeemable share rose to $10.29 from $10.02 at year-end 2025.

  • · Operating cash fell 37.1% from $1,395,995 to $877,781 year-to-date, with $518,214 used in operations, a meaningful drain on liquidity for a company with no operating business.
  • · Accounts payable and accrued expenses declined from $217,300 to $23,426, while amounts due to the Sponsor rose from $7,500 to $56,007.
  • · Net income per share was $0.06 for the quarter and $0.17 year-to-date for both redeemable and non-redeemable shares, entirely attributable to trust interest income rather than operations.
  • · The shareholders' deficit widened by $425,160 over nine months, reflecting remeasurement of redeemable shares to trust value and reducing the equity cushion.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Filings Daily Market Digest

🇺🇸 More from United States

View all →